Showing results (61-70 of 686) with videos related to

Sort By:
Pageof 69
Current Opinion in Cardiology|February 15, 2023
Are serum uric acid levels predictors of cardiovascular risk? An updateMichael Georgoulis, Dimitri P Mikhailidis, Demosthenes B Panagiotakos
Current Pharmaceutical Design|January 17, 2017
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk ManagementNiki Katsiki, Dimitri P Mikhailidis, Michael J Theodorakis
Current Pharmaceutical Design|January 5, 2021
Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular DiseaseNiki Katsiki, George D Dimitriadis, Dimitri P Mikhailidis
Current Opinion in Cardiology|April 18, 2013
Epicardial fat and vascular risk: a narrative reviewNiki Katsiki, Dimitri P Mikhailidis, Anthony S Wierzbicki
Journal of Cardiovascular Pharmacology and Therapeutics|April 12, 2021
Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes?Emir M Muzurović, Snežana Vujošević, Dimitri P Mikhailidis
Seizure|July 17, 2014
The effects of antiepileptic drugs on vascular risk factors: a narrative reviewNiki Katsiki, Dimitri P Mikhailidis, Devaki R Nair
Annals of Medicine|January 25, 2011
Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?Niki Katsiki, Apostolos I Hatzitolios, Dimitri P Mikhailidis
Current Opinion in Cardiology|April 12, 2011
Pulmonary arterial hypertension and statins: an updateNiki Katsiki, Anthony S Wierzbicki, Dimitri P Mikhailidis
Angiology|April 11, 2019
The Role of n-3 Fatty Acids in Cardiovascular Disease: Back to the FuturePablo Perez-Martinez, Niki Katsiki, Dimitri P Mikhailidis
Current Vascular Pharmacology|July 27, 2016
Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?Niki Katsiki, Vasilios G Athyros, Dimitri P Mikhailidis
Pageof 69